Platelet Activation Dynamics in Kawasaki Disease– Revisited

  • Pandiarajan Vignesh
  • Surjit SinghEmail author
Editorial Commentary


Compliance with Ethical Standards

Conflict of Interest


Source of Funding



  1. 1.
    McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135:e927–99.CrossRefGoogle Scholar
  2. 2.
    Yahata T, Suzuki C, Yoshioka A, Hamaoka A, Ikeda K. Platelet activation dynamics evaluated using platelet-derived microparticles in Kawasaki disease. Circ J. 2014;78:188–93.CrossRefGoogle Scholar
  3. 3.
    Jin J, Wang J, Lu Y, et al. Platelet-derived microparticles: a new index of monitoring platelet activation and inflammation in Kawasaki disease. Indian J Pediatr. 2018.
  4. 4.
    Ueno K, Nomura Y, Morita Y, Eguchi T, Masuda K, Kawano Y. Circulating platelet-neutrophil aggregates play a significant role in Kawasaki disease. Circ J. 2015;79:1349–56.CrossRefGoogle Scholar
  5. 5.
    Laurito M, Stazi A, Delogu AB, et al. Endothelial and platelet function in children with previous Kawasaki disease. Angiology. 2014;65:716–22.CrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2019

Authors and Affiliations

  1. 1.Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics CentrePostgraduate Institute of Medical Education and ResearchChandigarhIndia

Personalised recommendations